$ACB.TO

Curaleaf Says Aurora Offer Gives Shareholders "Meaningful" Future Upside

Curaleaf (CURA.TO) on Wednesday reiterated its statement that its hostile offer to acquire Aurora Cannabis (ACB.TO) shares for an offer price of $4.00 and capped at $5.00 each offers a "meaningful" future upside.Aurora shareholders would be able to realize immediate value and participate in the growth of a much larger, more diversified cannabis platform, Curaleaf added.It was responding to statements made by Aurora earlier today where it urged shareholders to reject Curaleaf's offer, describing the bid as "hostile" and "inadequate", and one which aimed to capture Aurora's assets at a discount.Curaleaf shares were last seen up C$0.20 to C$13.86, while Aurora Cannabis shares were up C$0.02 to C$5.62.Price: $13.88, Change: $+0.22, Percent Change: +1.61%

Aurora Cannabis Urges Shareholders to Reject Curaleaf's Takeover Bid

Aurora Cannabis (ACB.TO) urged shareholders to reject Curaleaf Holdings (CURA.TO)'s unsolicited takeover bid, saying that the offer undervalues the company, Aurora said Wednesday.Aurora said Curaleaf is seeking to acquire Aurora's assets at a discount, adding that Curaleaf's debt of over C$1 billion would put Aurora shareholders at risk.The board of Aurora recommended that Aurora shareholders take no action on the bid, and told shareholders who have tendered their shares to the bid to withdraw those shares.Aurora said the company's standalone strategy to exit lower-margin businesses, expand cultivation and manufacturing capacity, and develop an international platform offers better value for shareholders."Curaleaf has over a C$1 billion in debt and is asking shareholders to give up ownership of a stronger, debt-free and growing global medical cannabis company in exchange for an offer with intentionally limited upside, that does not reflect Aurora's fundamental value, exposes shareholders to Curaleaf's risks and would leave shareholders with limited voting influence in a combined company," Aurora Executive Chairman and CEO Miguel Martin said.

Update: Aurora Cannabis Acquiring UK Company For 2 Million Pounds Cash

(Updates shares and adds detail on Aurora's UK acquisition in the first two paragraphs.)Aurora Cannabis (ACB.TO), which is fending off a hostile takeover bid by Curaleaf (CURA.TO) Wednesday afternoon said it acquired importer and wholesaler Internode Pharma and HAP Pharma, a pharmacy, both in the UK, for 2.1 million pounds cash.The companies operate an import and distribution facility and a virtual pharmacy in England, and provide Aurora with a supply chain from cultivation through to delivery to patients, a statement said.Aurora earlier today urged shareholders to ignore an unsolicited offer by Curaleaf Holdings (CURA.TO) after it launched its bid for Aurora shares at $4.00 each on Tuesday, consisting of 0.3463 subordinate voting share of Curaleaf and $0.75 in cash per Aurora share.Aurora Cannabis shares were last seen up C$0.22, or 4.3%, to C$5.32 on the Toronto Stock Exchange.Price: $5.31, Change: $+0.21, Percent Change: +4.12%

Aurora Cannabis Tells Shareholders to Ignore Curaleaf's Unsolicited Offer

Aurora Cannabis (ACB.TO) Wednesday morning urged shareholders to take no action on the unsolicited offer by Curaleaf Holdings (CURA.TO).Curaleaf launched its unsolicited take-over bid for Aurora shares at $4.00 each on Tuesday, consisting of 0.3463 subordinate voting share of Curaleaf and $0.75 in cash per Aurora share."Contrary to assertions by Curaleaf, our door is always open to those that see value in our company," said Aurora CEO Miguel Martin. He added that Aurora had been in dialogue with Curaleaf since June 22, and "as recently" as August 12, 2026."Their objective is to acquire Aurora's highly strategic EU-GMP facilities and leading medical cannabis platforms at the lowest price possible, thereby depriving Aurora shareholders of any current and future value they generate," Martin said.Aurora Cannabis shares were last seen up C$0.08, to C$5.18, on the Toronto Stock Exchange. Curaleaf shares were up C$0.10, to C$12.90.Price: $5.17, Change: $+0.07, Percent Change: +1.37%

Curaleaf Launches Unsolicited Take-Over Bid to Buy Aurora Cannabis

Curaleaf (CURA.TO)on Tuesday formally launched its unsolicited takeover bid for Aurora Cannabis (ACB.TO, ACB), it said in a statement on Tuesday.The deal would allow Aurora shareholders to receive total implied consideration of $4.00 per Aurora common share, comprised of 0.3463 of a Curaleaf subordinate voting share and $0.75 in cash and based on Curaleaf's closing share price of $9.39 on Aug. 10, which was the day before the company announced its intention to make the offer. The offer is subject to a maximum value per share of $5.00."Aurora Cannabis, in its response to Curaleaf's Aug. 10 press release noted that the proposal added a cap on the value of the consideration of $5.00 per Aurora share, which is a lower price than Aurora shares have traded as recently as Dec.18, 2025. Aurora Cannabis had also said that its board intended to form a special committee of independent directors to consider the proposal.Curaleaf acknowledged the formation of Aurora Cannabis' Special Committee to review the offer."We remain disappointed that Aurora's management and Board have not meaningfully engaged with us on the merits of our proposal. A one-line response to an offer is not meaningful engagement - it is a dismissal - and Aurora shareholders deserve the opportunity to fully evaluate the potential benefits of this transaction," said Curaleaf chief executive Boris Jordan."However, we are hopeful that Aurora's Special Committee will see, as we do, that the financial and strategic rationales for a combination with Curaleaf are compelling, and that this transaction is in the best interest of Aurora shareholders. We remain available for productive conversations with the Special Committee to ensure that the benefits of the combination can be realized by the shareholders of both of our companies as soon as possible," Jordan continued.Curaleaf's offer will remain open for acceptance until 5:00 p.m., Mountain Time, on Dec. 1, unless extended, varied or withdrawn in accordance with its terms, it said.Shares of Curaleaf were last seen down 2.5% at C$12.66 on the Toronto Stock Exchange. Aurora Cannabis shares were up 3% at C$5.15 on the TSX.Price: $12.93, Change: $-0.06, Percent Change: -0.46%

Update: Curaleaf Proposing to Acquire Aurora Cannabis For $4.00 Per Share

(Updates with Aurora Cannabis' response in the fifth, sixth and seventh paragraphs and updates shares in final paragraph.)Curaleaf Holdings (CURA.TO) on Tuesday said it is proposing to acquire Aurora Cannabis (ACB.TO) at $4.00 per share.It is making its intention public after two attempts to engage with the Aurora board had met with silence, Curaleaf said. It sent a formal letter of intent on June 23 outlining Curaleaf's proposal, and a follow-up letter on July 7. No formal offer has been made.The offer, comprised of 0.35 of a Curaleaf share, plus $0.75 cash per Aurora share, implies a 45% premium based on Aurora's 30-day volume weighted average price (VWAP) of $2.75.The Curaleaf statement noted the combined company would have a footprint in 17 countries spanning Europe, North America, and other emerging international markets.Aurora confirmed on Tuesday afternoon that it received Curaleaf's unsolicited takeover proposal. The company also pushed back on Curaleaf's claim that it refused to engage and said its lead independent director remained in contact with Curaleaf's CEO as recently as July 24.The board plans to form a special committee of independent directors to review the proposal and determine what is in the best interests of Aurora and its shareholders, the company added."No decision has been made with respect to the proposal, and there can be no assurance that the proposal will result in any transaction," Aurora said.Aurora shares closed up C$1.00, or 25%, to C$5.03 on the Toronto Stock Exchange, whlle Curaleaf rose C$0.72, or 5.5%, to C$13.80.

Curaleaf Proposing to Acquire Aurora Cannabis For $4.00 Per Share

Curaleaf Holdings (CURA.TO) on Tuesday said it is proposing to acquire Aurora Cannabis (ACB.TO) at $4.00 per share.It is making its intention public after two attempts to engage with the Aurora board had met with silence, Curaleaf said. It sent a formal letter of intent on June 23 outlining Curaleaf's proposal, and a follow-up letter on July 7. No formal offer has been made.The offer, comprised of 0.35 of a Curaleaf share, plus $0.75 cash per Aurora share, implies a 45% premium based on Aurora's 30-day volume weighted average price (VWAP) of $2.75.The Curaleaf statement noted the combined company would have a footprint in 17 countries spanning Europe, North America, and other emerging international markets.Aurora Cannabis has not yet released a statement.Curaleaf shares were last seen up C$0.16, to C$13.24, on the Toronto Stock Exchange, while Aurora Cannabis shares jumped 20.35% to C$4.85.Price: $13.21, Change: $+0.13, Percent Change: +0.99%

S&P/TSX Composite Index up Nearly 107 Points Mid-Morning Tuesday

The S&P/TSX Composite Index, is up near 107 points mid-morning Tuesday with most sectors higher.Utilities and telecommunications are the best performers, gaining 1.1% each, followed by the industrials sector, up 0.8%.Limiting gains is information technology, down 0.8%.The S&P/TSX Battery Metals Index, which includes issues listed both on the TSX and TSX Venture Exchange, was 4.1%, on last look.In stocks, Pet Valu (PET.TO), jumped nearly 10.4% to C$20.75, after it reported a second-quarter adjusted earnings beat earlier Tuesday.Cannabis company Aurora Cannabis (ACB.TO) surged 20.4% to C$4.83 after Curaleaf (CURA.TO) announced its plans to acquire the company for $4.00 per share.

Aurora Cannabis Says Niagara Facility Obtains EU-GMP Certification

Aurora Cannabis (ACB.TO) said Thursday that its subsidiary Safari Flower Company, has received European Union Good Manufacturing Practice (EU-GMP) certification for its Niagara facility.The certification is granted for a three-year term. Aurora acquired Safari Flower in April.

Aurora Cannabis Down 4% in U.S. Pre-Market After It Forecast a Decline in Fiscal Year 2027 Total Net Revenue

U.S.-listed shares of Aurora Cannabis (ACB.TO, ACB) fell 4% in pre-market trading on Thursday after it said it expects fiscal year 2027 total net revenue to decline and be more in line with its Cannabis net revenue results in fiscal year 2025, following the changes in Canadian medical partially offset by international growth, driven by Germany and Poland.For the three months ended March 31, 2026, the company reported adjusted net income of $5.6 million, compared with $15.3 million, a year earlier.Net revenue increased to $84.8 million in the fourth quarter, compared with $76.8 million, a year-ago, due to a 14% growth in its global medical cannabis business and higher wholesale bulk cannabis net revenue, offset by lower quarterly net revenue in its consumer cannabis business, it said. The result beat a consensus estimate compiled by FactSet of $75.7 million."Over the next few quarters, we are purposely investing in our international business through strategic sales initiatives and EU GMP capacity expansion to support growth in our most profitable markets," said the company in a statement. "These efforts are expected to help offset the impact of margin reductions in our Canadian medical business, following the reduction in government reimbursed pricing, effective April 1, 2026."Adjusted EBITDA in fiscal year 2027 is expected to vary quarter over quarter, leading to lower annual adjusted EBITDA compared to the prior fiscal year, it added.Shares of the company closed down 2.9% to $4.59 on Wednesday on the Toronto Stock Exchange.

Aurora Cannabis Says This Certification Gives It Exclusive Rights to "Grow, Propagate, and Sell Finished Products Produced From These Varieties"

Aurora Cannabis Granted Plant Breeders' Rights in Canada for Two Proprietary Cannabis Cultivars

Aurora Cannabis Launching New Medical Cannabis Products Globally

Aurora Cannabis (ACB.TO) is "significantly" expanding its global medical cannabis portfolio, with product launches rolling out across Canada, Europe and Australia, the company said on Tuesday.The newly expanded lineup includes dried flower, pre-rolls and pastilles, and will be rolled out between now and June, a statement added."By expanding our offerings in key countries, we're responding to clear patient and prescriber demand with products that meet local regulatory standards, offer meaningful choice across formats, and can be supplied reliably at scale - all while reinforcing the level of quality and trust expected from us," said Lana Culley, who heads innovation and international operations at Aurora.Aurora shares were last seen down US$0.08, to US$3.43 in U.S. pre-market trading.

Aurora Advancing Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets

Aurora Cannabis Acquires Safari Flower Company, Boosting EU GMP Capacity

Aurora Cannabis (ACB.TO) said Wednesday that it has acquired Safari Flower Company, a European certified cannabis cultivator and manufacturer in a transaction valued at $26.5 million.Aurora issued 2.42 million shares and paid the selling shareholder $15 million in cash. The transaction also includes a $2 million cash payment if certain conditions are met, a statement said.This transaction is expected to deliver positive adjusted EBITDA contributions in fiscal year 2027. Safari Flower's 59,000 square foot, indoor cultivation and manufacturing facility, in Ontario, will provide incremental capacity and be used to supply EU GMP flower to Aurora's key markets, including Germany, Australia, Poland, and the UK, and support further market expansion."The acquisition of Safari Flower Company marks an important milestone for Aurora as we continue to purposefully invest in expanding our EU GMP capacity to support the rapidly growing international medical cannabis market," said Aurora chief executive Miguel Martin.Aurora Cannabis shares are unchanged at US$3.53 in New York trading.

Aurora Cannabis Says Buy Expands Its EU GMP Capacity to "Serve Growing High Margin International Markets"

- -Aurora Cannabis Makes "Accretive" Acquisition of Safari Flower Company